Works by Rajith, K R


Results: 16
    1
    2
    3
    4

    Lack of antiviral activity of probenecid in vitro and in Syrian golden hamsters.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 1, p. 172, doi. 10.1093/jac/dkad362
    By:
    • Box, Helen J;
    • Sharp, Joanne;
    • Pennington, Shaun H;
    • Kijak, Edyta;
    • Tatham, Lee;
    • Caygill, Claire H;
    • Lopeman, Rose C;
    • Jeffreys, Laura N;
    • Herriott, Joanne;
    • Neary, Megan;
    • Valentijn, Anthony;
    • Pertinez, Henry;
    • Curley, Paul;
    • Arshad, Usman;
    • Rajoli, Rajith K R;
    • Jochmans, Dirk;
    • Vangeel, Laura;
    • Neyts, Johan;
    • Chatelain, Eric;
    • Escudié, Fanny
    Publication type:
    Article
    5
    6
    7

    Prioritization of Anti‐SARS‐Cov‐2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics.

    Published in:
    Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 4, p. 775, doi. 10.1002/cpt.1909
    By:
    • Arshad, Usman;
    • Pertinez, Henry;
    • Box, Helen;
    • Tatham, Lee;
    • Rajoli, Rajith K. R.;
    • Curley, Paul;
    • Neary, Megan;
    • Sharp, Joanne;
    • Liptrott, Neill J.;
    • Valentijn, Anthony;
    • David, Christopher;
    • Rannard, Steve P.;
    • O'Neill, Paul M.;
    • Aljayyoussi, Ghaith;
    • Pennington, Shaun H.;
    • Ward, Stephen A.;
    • Hill, Andrew;
    • Back, David J.;
    • Khoo, Saye H.;
    • Bray, Patrick G.
    Publication type:
    Article
    8

    Dose prediction for repurposing nitazoxanide in SARS‐CoV‐2 treatment or chemoprophylaxis.

    Published in:
    British Journal of Clinical Pharmacology, 2021, v. 87, n. 4, p. 2078, doi. 10.1111/bcp.14619
    By:
    • Rajoli, Rajith K. R.;
    • Pertinez, Henry;
    • Arshad, Usman;
    • Box, Helen;
    • Tatham, Lee;
    • Curley, Paul;
    • Neary, Megan;
    • Sharp, Joanne;
    • Liptrott, Neill J.;
    • Valentijn, Anthony;
    • David, Christopher;
    • Rannard, Steven P.;
    • Aljayyoussi, Ghaith;
    • Pennington, Shaun H.;
    • Hill, Andrew;
    • Boffito, Marta;
    • Ward, Steve A.;
    • Khoo, Saye H.;
    • Bray, Patrick G.;
    • O'Neill, Paul M.
    Publication type:
    Article
    9

    Assessment of Favipiravir and Remdesivir in Combination for SARS-CoV-2 Infection in Syrian Golden Hamsters.

    Published in:
    Viruses (1999-4915), 2024, v. 16, n. 12, p. 1838, doi. 10.3390/v16121838
    By:
    • Neary, Megan;
    • Gallardo-Toledo, Eduardo;
    • Sharp, Joanne;
    • Herriott, Joanne;
    • Kijak, Edyta;
    • Bramwell, Chloe;
    • Cox, Helen;
    • Tatham, Lee;
    • Box, Helen;
    • Curley, Paul;
    • Arshad, Usman;
    • Rajoli, Rajith K. R.;
    • Pertinez, Henry;
    • Valentijn, Anthony;
    • Pennington, Shaun H.;
    • Caygill, Claire H.;
    • Lopeman, Rose C.;
    • Biagini, Giancarlo A.;
    • Kipar, Anja;
    • Stewart, James P.
    Publication type:
    Article
    10
    11

    Evaluation of Nafamostat as Chemoprophylaxis for SARS-CoV-2 Infection in Hamsters.

    Published in:
    Viruses (1999-4915), 2023, v. 15, n. 8, p. 1744, doi. 10.3390/v15081744
    By:
    • Neary, Megan;
    • Sharp, Joanne;
    • Gallardo-Toledo, Eduardo;
    • Herriott, Joanne;
    • Kijak, Edyta;
    • Bramwell, Chloe;
    • Cox, Helen;
    • Tatham, Lee;
    • Box, Helen;
    • Curley, Paul;
    • Arshad, Usman;
    • Rajoli, Rajith K. R.;
    • Pertinez, Henry;
    • Valentijn, Anthony;
    • Dhaliwal, Kevin;
    • Mc Caughan, Frank;
    • Hobson, James;
    • Rannard, Steve;
    • Kipar, Anja;
    • Stewart, James P.
    Publication type:
    Article
    12

    Unlike Chloroquine, Mefloquine Inhibits SARS-CoV-2 Infection in Physiologically Relevant Cells.

    Published in:
    Viruses (1999-4915), 2022, v. 14, n. 2, p. 374, doi. 10.3390/v14020374
    By:
    • Sacramento, Carolina Q.;
    • Fintelman-Rodrigues, Natalia;
    • Dias, Suelen S. G.;
    • Temerozo, Jairo R.;
    • Da Silva, Aline de Paula D.;
    • da Silva, Carine S.;
    • Blanco, Camilla;
    • Ferreira, André C.;
    • Mattos, Mayara;
    • Soares, Vinicius C.;
    • Pereira-Dutra, Filipe;
    • Miranda, Milene Dias;
    • Barreto-Vieira, Debora F.;
    • da Silva, Marcos Alexandre N.;
    • Santos, Suzana S.;
    • Torres, Mateo;
    • Chaves, Otávio Augusto;
    • Rajoli, Rajith K. R.;
    • Paccanaro, Alberto;
    • Owen, Andrew
    Publication type:
    Article
    13
    14
    15

    An Open Label, Adaptive, Phase 1 Trial of High‐Dose Oral Nitazoxanide in Healthy Volunteers: An Antiviral Candidate for SARS‐CoV‐2.

    Published in:
    Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 3, p. 585, doi. 10.1002/cpt.2463
    By:
    • Walker, Lauren E.;
    • FitzGerald, Richard;
    • Saunders, Geoffrey;
    • Lyon, Rebecca;
    • Fisher, Michael;
    • Martin, Karen;
    • Eberhart, Izabela;
    • Woods, Christie;
    • Ewings, Sean;
    • Hale, Colin;
    • Rajoli, Rajith K. R.;
    • Else, Laura;
    • Dilly‐Penchala, Sujan;
    • Amara, Alieu;
    • Lalloo, David G.;
    • Jacobs, Michael;
    • Pertinez, Henry;
    • Hatchard, Parys;
    • Waugh, Robert;
    • Lawrence, Megan
    Publication type:
    Article
    16